SPEVOLZA Trademark

Trademark Overview


On Thursday, July 13, 2023, a trademark application was filed for SPEVOLZA with the United States Patent and Trademark Office. The USPTO has given the SPEVOLZA trademark a serial number of 79376849. The federal status of this trademark filing is REGISTERED as of Tuesday, March 12, 2024. This trademark is owned by NOVARTIS AG. The SPEVOLZA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
spevolza

General Information


Serial Number79376849
Word MarkSPEVOLZA
Filing DateThursday, July 13, 2023
Status700 - REGISTERED
Status DateTuesday, March 12, 2024
Registration Number7324663
Registration DateTuesday, March 12, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 26, 2023

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 11, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Monday, September 11, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 17, 2023SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Friday, September 1, 2023LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, September 15, 2023APPLICATION FILING RECEIPT MAILED
Monday, October 16, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 16, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 16, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 16, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 16, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, October 16, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 16, 2023ASSIGNED TO EXAMINER
Tuesday, November 21, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 6, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 26, 2023PUBLISHED FOR OPPOSITION
Tuesday, December 26, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, December 29, 2023INTERNATIONAL REGISTRATION RENEWED
Tuesday, March 12, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, March 12, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Friday, April 12, 2024FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, January 15, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, April 11, 2024GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Friday, April 12, 2024FINAL DISPOSITION PROCESSED
Monday, May 6, 2024NOTIFICATION PROCESSED BY IB
Wednesday, January 15, 2025NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Saturday, February 8, 2025NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB